Denali Therapeutics Stock Forecast - Accumulation Distribution

DNLI Stock  USD 20.77  0.54  2.53%   
Denali Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Denali Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
As of now, Denali Therapeutics' Receivables Turnover is increasing as compared to previous years. The Denali Therapeutics' current Asset Turnover is estimated to increase to 0.30, while Inventory Turnover is projected to decrease to (1.33). . The current Common Stock Shares Outstanding is estimated to decrease to about 86.7 M. The Denali Therapeutics' current Net Loss is estimated to increase to about (278.7 M).

Open Interest Against 2024-06-21 Denali Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Denali Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Denali Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Denali Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Denali Therapeutics' open interest, investors have to compare it to Denali Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Denali Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Denali. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
On September 29, 2023 Denali Therapeutics had Accumulation Distribution of 21269.66.
Most investors in Denali Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Denali Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Denali Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
The accumulation distribution (A/D) indicator shows the degree to which Denali Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Denali Therapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by Denali Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.
Check Denali Therapeutics VolatilityBacktest Denali TherapeuticsTrend Details  

Denali Therapeutics Trading Date Momentum

On October 02 2023 Denali Therapeutics was traded for  19.79  at the closing time. The top price for the day was 20.53  and the lowest listed price was  19.67 . The trading volume for the day was 1.6 M. The trading history from October 2, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.07% . The overall trading delta against the current closing price is 0.44% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Denali Therapeutics to competition

Other Forecasting Options for Denali Therapeutics

For every potential investor in Denali, whether a beginner or expert, Denali Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Denali Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Denali. Basic forecasting techniques help filter out the noise by identifying Denali Therapeutics' price trends.

Denali Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Denali Therapeutics stock to make a market-neutral strategy. Peer analysis of Denali Therapeutics could also be used in its relative valuation, which is a method of valuing Denali Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Denali Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Denali Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Denali Therapeutics' current price.

Denali Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Denali Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Denali Therapeutics shares will generate the highest return on investment. By undertsting and applying Denali Therapeutics stock market strength indicators, traders can identify Denali Therapeutics entry and exit signals to maximize returns.

Denali Therapeutics Risk Indicators

The analysis of Denali Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Denali Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting denali stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Denali Stock

When determining whether Denali Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Denali Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Denali Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Denali Therapeutics Stock:
Check out Historical Fundamental Analysis of Denali Therapeutics to cross-verify your projections.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.94)
Revenue Per Share
2.101
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.09)
Return On Equity
(0.11)
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.